Adverse drug reactions during drug-resistant TB treatment in high HIV prevalence settings: a systematic review and meta-analysis | Zendy

Kathryn Schnippel | Zendy; Cynthia Firnhaber | Zendy; Rebecca Berhanu | Zendy; Liesl PageShipp | Zendy; Edina Sinanovic | Zendy

Open Access

Adverse drug reactions during drug-resistant TB treatment in high HIV prevalence settings: a systematic review and meta-analysis

Author(s) -

Kathryn Schnippel,

Cynthia Firnhaber,

Rebecca Berhanu,

Liesl PageShipp,

Edina Sinanovic

Publication year - 2017

Publication title -

journal of antimicrobial chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.124

H-Index - 194

eISSN - 1460-2091

pISSN - 0305-7453

DOI - 10.1093/jac/dkx107

Subject(s) - medicine , concomitant , context (archaeology) , coinfection , adverse effect , meta analysis , immunosuppression , cohort study , observational study , relative risk , drug , human immunodeficiency virus (hiv) , confidence interval , immunology , pharmacology , paleontology , biology

To estimate the prevalence of adverse drug reactions or events (ADR) during drug-resistant TB (DR-TB) treatment in the context of settings with high HIV prevalence (at least 20% of patients).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research